2025-11-06 - Analysis Report
Okay, here's a comprehensive analysis of Exxon Mobil Corp (XOM) based on the data you provided.

**Report on Exxon Mobil Corp (XOM)**

**0. Overview**

This report analyzes Exxon Mobil Corp (XOM) based on recent performance, market indicators, news, analyst opinions, earnings, and financial data. The goal is to provide a concise overview for investment consideration.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** XOM
*   **Company:** Exxon Mobil Corp
*   **Description:** Exxon Mobil Corp is a major integrated oil and gas company involved in exploration, production, refining, and marketing of oil and gas products.

**Key Performance Metrics:**

*   **XOM Cumulative Return:** 19.27%
*   **VOO (S&P 500) Cumulative Return:** 99.52%
*   **Absolute Divergence:** -82.6% (XOM underperformed VOO by this amount)
*   **Relative Divergence:** 13.1% (XOM's current divergence is at the 13.1th percentile of its historical range vs. VOO)

**Analysis:** XOM has significantly underperformed the S&P 500 over the period. The relative divergence indicates that this underperformance is near the lower end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2015-2017  | 9.0%   | 65.6% | -19.0%  | 0.0    | 352.8  |
| 2016-2018  | -5.0%  | 71.1% | -21.0%  | 0.1    | 287.6  |
| 2017-2019  | -6.0%  | 71.1% | -28.0%  | -0.5   | 294.3  |
| 2018-2020  | -34.0% | 78.8% | -57.0%  | -0.4   | 173.9  |
| 2019-2021  | -3.0%  | 78.8% | -49.0%  | -0.9   | 258.1  |
| 2020-2022  | 48.0%  | 81.8% | 48.0%   | -0.1   | 465.2  |
| 2021-2023  | 39.0%  | 81.8% | 37.0%   | 0.5    | 421.7  |
| 2022-2024  | 7.0%   | 81.8% | -13.0%  | 0.8    | 453.7  |
| 2023-2025  | -18.0% | 77.7% | -82.0%  | 1.3    | 482.7  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate varies significantly over the periods, showing volatility in Exxon Mobil's performance. Recent years (2023-2025) show negative growth.
*   **MDD:** High Maximum Drawdown values indicate significant risk and price volatility.
*   **Alpha:** The alpha is mostly negative, particularly in recent periods, indicating underperformance relative to the benchmark.  The exception being 2020-2023.
*   **Beta:** The beta values vary but have been increasing.  Beta > 1 suggests XOM is more volatile than the market.
*   **Cap:** The Market Cap has generally increased, suggesting growth in the company's overall value despite performance fluctuations.

**2. Recent Stock Price Movements**

*   **Current Price:** 114.4364
*   **Last Market Data:** Price: 114.435, Previous Close: 114.14, Change: 0.26
*   **5-Day Moving Average:** 114.7393
*   **20-Day Moving Average:** 113.6396
*   **60-Day Moving Average:** 112.3929

**Analysis:** The current price is slightly below the 5-day moving average but above the 20-day and 60-day moving averages. This suggests a recent upward trend, but with a potential short-term pullback.  The small price change from the previous close suggests no major immediate price catalyst.

**3. Technical Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 62.07 (Neutral to slightly overbought)
*   **PPO:** -0.0178 (Slightly bearish, indicates the short-term moving average is slightly below the long-term moving average)
*   **Hybrid Signal:** "cash\_0% Buy 100% of cash (9 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00)" - Suggests a strong buy signal based on the MRI, recommending full allocation and ongoing investment.
*   **Recent (20-day) Relative Divergence Change:** -0.9 (Short-term decline)
*   **Expected Return (%):** -176.0 - Significantly negative; indicating potential underperformance compared to the S&P 500 over a 2+ year investment horizon.

**Analysis:**

*   Despite the "High Investment Recommended" MRI and the buy signal, the extremely negative expected return is a major concern.  This suggests that the MRI might be an outlier or that other factors are heavily weighing on the long-term outlook.
*   The recent decline in relative divergence aligns with the slightly bearish PPO.

**4. Recent News & Significant Events:**

*   **Fighting Giants Comes With a Price:**  Lawsuit implication and ongoing battle with competitors.
*   **ExxonMobil Stock: Buy, Hold, or Take Profits After Q3 Earnings?:** Mixed outlook based on earnings.
*   **How to Find Strong Oils-Energy Stocks Slated for Positive Earnings Surprises:** Sector-wide analysis, potentially relevant to XOM.
*   **ExxonMobil Names Jon Gibbs to Lead New Global Operations Division:** Internal leadership change.
*   **Correction (The Wall Street Journal):** Potentially unrelated to XOM specifically.
*   **BP Just Shocked Wall Street:** Competitor news, relevant for sector context.

**Analysis:** Recent news is mixed. While some articles suggest a potentially positive outlook based on earnings, others highlight ongoing legal battles and internal changes. The BP news affects the sector sentiment.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.26)
*   **Target Price:** Average: 127.24 / High: 156.00 / Low: 105.00
*   **Recent Rating Changes:** No recent changes indicated.

**Analysis:** Analysts generally have a "Buy" rating on XOM with a substantial upside potential based on the average target price. The absence of recent rating changes suggests stability in analyst sentiment.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 예상 EPS |
|------------|------|----------|
| 2025-10-31 | 1.88 | 1.82     |
| 2025-08-01 | 1.64 | 1.57     |
| 2025-05-02 | 1.76 | 1.75     |
| 2025-01-31 | 1.67 | 1.77     |
| 2024-11-01 | 1.92 | 1.88     |

**Analysis:** XOM has generally exceeded EPS expectations in recent quarters. However, the 2025-01-31 data shows EPS fell short of expectations.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $79.48B  | 22.58%        |
| 2025-03-31 | $81.06B  | 22.80%        |
| 2024-12-31 | $81.06B  | 21.28%        |
| 2024-09-30 | $87.79B  | 23.23%        |
| 2024-06-30 | $89.99B  | 22.44%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE    |
|------------|-----------|--------|
| 2025-06-30 | $262.59B  | 2.70%  |
| 2025-03-31 | $262.72B  | 2.94%  |
| 2024-12-31 | $263.70B  | 2.89%  |
| 2024-09-30 | $268.59B  | 3.21%  |
| 2024-06-30 | $268.40B  | 3.44%  |

**Analysis:**

*   **Revenue:** Revenue has been declining slightly in recent quarters.
*   **Profit Margin:** Profit margins have remained relatively stable, indicating efficient cost management.
*   **Equity:** Equity has remained relatively stable.
*   **ROE:** ROE has also been decreasing, which can be attributed to the decline in revenue.

**7. Overall Summary and Considerations:**

**Summary:** Exxon Mobil (XOM) presents a mixed picture.

*   **Negatives:** Significant underperformance relative to the S&P 500, very negative expected return, recent decline in revenue and ROE, news highlighting legal challenges, and negative alpha values in the Alpha/Beta analysis.
*   **Positives:** Analyst "Buy" consensus with a target price above the current price, recent earnings generally exceeding expectations, high Market Risk Indicator (MRI), and a buy signal from the Hybrid Signal.

**Overall:** The negative expected return significantly outweighs the positive indicators. While analysts are optimistic and the company has shown strong earnings, the long-term outlook based on the model suggests potential underperformance compared to the overall market.

**Recommendation:** Due to the extremely negative expected return and underperformance against the S&P 500, a cautious approach is warranted. It may be best to hold or reduce existing positions until the long-term outlook improves. Further investigation into the factors contributing to the negative expected return is crucial before considering new investments. Also, consider the legal battles mentioned in the news headlines and how they might impact XOM's future.
